Roberta Barone Lumaga, Silvia Tagliamonte, Tiziana De Rosa, Vincenzo Valentino, Danilo Ercolini, Paola Vitaglione
Journal: The Journal of nutrition 2024;154(10):2976-2987
PMID: 39179206
Diet plays a key role in preventing cardiometabolic and chronic diseases, with dietary fibre known to reduce the risk of cardiovascular disease, cancer, type 2 diabetes, and obesity. This randomised controlled trial examined the effects of consuming a sourdough croissant enriched with 4.8% dietary fibre (FIBCRO) compared to a standard croissant (CONCRO) for two weeks in 32 healthy participants. Results showed that the fibre-enriched croissant improved fasting blood glucose control. This was linked to increased urinary levels of urolithin A, an anti-inflammatory microbial metabolite, and reduced one enzyme involved in regulating blood sugar levels, independent of diet, appetite, physical activity, or gut microbiome changes. The authors suggest that fibre-enriched bakery products made from agro-industrial byproducts could support blood glucose control and offer additional health benefits based on the fibre and polyphenol content.
BACKGROUND
An incorrect lifestyle, including diet, is responsible for the worldwide dramatic increase in obesity and type 2 diabetes. Increasing dietary fiber consumption may lead to health benefits, and reformulation of bakery products may be a strategy to globally improve the diet.
OBJECTIVES
This study aimed to assess the impact of a 2-wk breakfast consumption with a sourdough-leavened croissant containing a blend of dietary fiber from 10 sources (4.8 g/100 g, croissant enriched with dietary fibers [FIBCRO]), compared with a control croissant (dietary fibers 1.3 g/100 g, CONCRO) on daily energy intake, appetite, metabolic variables, and the gut microbiome.
METHODS
Thirty-two healthy participants were randomly allocated to 2 groups consuming FIBCRO or CONCRO. Participants self-recorded their diet and appetite through 7-d weighted food diaries and visual analog scales every day over the 2 wk. At baseline and after the intervention, fasting blood and urine samples, and fecal samples were collected beside blood pressure, anthropometry, and body composition. Serum glucose, lipids, C-reactive protein, and insulin according to the official methods and serum dipeptidyl peptidase-4 (DPPIV) activity by photometric method were measured. Polyphenols and urolithins in urines were analyzed by Liquid chromatography-tandem mass spectrometry (LC/MS/MS), whereas gut microbiome in feces by shotgun metagenomics.
RESULTS
FIBCRO consumption improved fasting blood glucose compared with CONCRO (mean changes from baseline -2.0 mg/dL in FIBCRO compared with +3.1 mg/dL in CONCRO, P = 0.022), also reducing serum DPPIV activity by 1.7 IU/L (P = 0.01) and increasing urinary excretion of urolithin A-sulfate by 6.9 ng/mg creatinine (P = 0.04) compared with baseline. No further changes in any of the monitored variables or in the gut microbiome were detected.
CONCLUSIONS
Results suggested that a 2-wk consumption of a sourdough croissant claimed as "source of dietary fiber" improved fasting glycemia compared with a conventional sourdough croissant in healthy subjects. The reduced serum DPPIV activity and increased bioavailability of urolithin likely contributed to determine that effect independently from gut microbiome changes. This trial was registered at clinicaltrials.gov as NCT04999280.
Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.
Full Text Sources:
Medical:
Research Materials:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.